Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 20;22(1):149.
doi: 10.1186/s12890-022-01944-w.

Smoking: a leading factor for the death of chronic respiratory diseases derived from Global Burden of Disease Study 2019

Affiliations

Smoking: a leading factor for the death of chronic respiratory diseases derived from Global Burden of Disease Study 2019

Hui Gan et al. BMC Pulm Med. .

Abstract

Background: Smoking is believed as one of the major risk factors resulting in a variety of non-communicable diseases, such as lung cancer and chronic respiratory diseases (CRDs). However, the global burden of CRDs attributed to smoking has not been systematically studied, particularly across different temporal and spatial scales.

Methods: We conducted a systematic analysis of the Global Burden of CRDs and related risk factors using data from the Global Burden of Disease Study 2019. Incidence, death, risk factors, and other parameters such as estimated annual percentage change have been analyzed. We also compared various risk factors across regions, countries, and genders.

Results: Globally, the incidence of CRDs and deaths cases have increased in the last 30 years, while the corresponding age-standardized incidence rate (ASIR) and death rate (ASDR) have declined. Smoking was the leading risk factor for the death of CRDs all over the world. However, in low and low-middle Socio-demographic Index (SDI) areas, particulate matter pollution was the main risk factor leading to death from CRDs, while smoking was ranked first among the major risk factors in areas with middle, middle-high, or high SDI. Globally, gender differences in morbidity and mortality from CRDs were observed. Males had slightly more cases and ASIR of chronic respiratory diseases than females over the last 30 years. However, the mortality cases and ASDR in males were significantly higher than that of females. Furthermore, the ASDR of all major risk factors, specially smoking, was higher in men than in women.

Conclusions: CRDs were still major threats human health. The current study highlights the dominating roles of smoking for death risks resulting from CRDs, followed by PM pollution. Therefore, tobacco control and improving air quality are key to reducing deaths from CRDs.

Keywords: Chronic respiratory disease; Global disease burden; Particulate matter pollution; Smoking.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
New cases (a), death cases (b), ASIR (c) and ASDR (d) of Chronic respiratory diseases globally and in different SDI regions from 1990 to 2019
Fig. 2
Fig. 2
Age-standardized incidence and death rate (per 100,000) of four kinds of CRDs from 1990 to 2019 globally. a Age-standardized incidence rate (per 100,000); b Age-standardized death rate (per 100,000)
Fig. 3
Fig. 3
Comparison of the rankings and percentage changes in ASDR attributable to 10 risk factors in 1990 and 2019
Fig. 4
Fig. 4
The ASDRs attributable to the top 6 risk factors by SDI region from 1990 to 2019. a Globally; b low SDI region; c low-middle SDI region; d middle SDI region; e high-middle SDI region; f high SDI region
Fig. 5
Fig. 5
The ASDRs attributable to the top 6 risk factors in different countries and territories in 2019. Risk factors of ASDR of CRDs had gender differences related to SDI
Fig. 6
Fig. 6
Ratio of male to female ASDR attributable to risk factors globally and in different SDI regions from 1990 to 2019. a Globally; b low SDI region; c low-middle SDI region; d middle SDI region; e high-middle SDI region; f high SDI region

References

    1. Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R, et al. Grand challenges in chronic non-communicable diseases. Nature. 2007;450(7169):494–496. doi: 10.1038/450494a. - DOI - PubMed
    1. Unwin N, Alberti KG. Chronic non-communicable diseases. Ann Trop Med Parasitol. 2006;100(5–6):455–464. doi: 10.1179/136485906X97453. - DOI - PubMed
    1. Muka T, Imo D, Jaspers L, Colpani V, Chaker L, van der Lee SJ, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30(4):251–277. doi: 10.1007/s10654-014-9984-2. - DOI - PubMed
    1. Demaio AR, Kragelund Nielsen K, Pinkowski Tersbol B, Kallestrup P, Meyrowitsch DW. Primary Health Care: a strategic framework for the prevention and control of chronic non-communicable disease. Glob Health Action. 2014;7:24504. doi: 10.3402/gha.v7.24504. - DOI - PMC - PubMed
    1. Sousa Pinto G, Bader L, Billberg K, Criddle D, Duggan C, El Bizri L, et al. Beating non-communicable diseases in primary health care: The contribution of pharmacists and guidance from FIP to support WHO goals. Res Social Adm Pharm. 2020;16(7):974–977. doi: 10.1016/j.sapharm.2019.10.008. - DOI - PubMed

LinkOut - more resources